BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23157358)

  • 1. Genomic biomarkers for patient selection and stratification: the cancer paradigm.
    Moschos SA
    Bioanalysis; 2012 Oct; 4(20):2499-511. PubMed ID: 23157358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker-driven patient selection for early clinical trials.
    Dienstmann R; Rodon J; Tabernero J
    Curr Opin Oncol; 2013 May; 25(3):305-12. PubMed ID: 23493192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From genomic landscapes to personalized cancer management-is there a roadmap?
    Swanton C; Caldas C
    Ann N Y Acad Sci; 2010 Oct; 1210():34-44. PubMed ID: 20973797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized medicine in oncology: tailoring the right drug to the right patient.
    Jiang Y; Wang M
    Biomark Med; 2010 Aug; 4(4):523-33. PubMed ID: 20701441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular markers for cancer prognosis and treatment: have we struck gold?
    Nowsheen S; Aziz K; Panayiotidis MI; Georgakilas AG
    Cancer Lett; 2012 Dec; 327(1-2):142-52. PubMed ID: 22120674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic sequencing for cancer diagnosis and therapy.
    Wang L; Wheeler DA
    Annu Rev Med; 2014; 65():33-48. PubMed ID: 24274147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular biology in medical oncology: diagnosis, prognosis, and precision medicine.
    Aftimos PG; Barthelemy P; Awada A
    Discov Med; 2014 Feb; 17(92):81-91. PubMed ID: 24534471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of DNA and tissue microarray technology to the identification and validation of biomarkers and personalised medicine in breast cancer.
    Brennan DJ; Kelly C; Rexhepaj E; Dervan PA; Duffy MJ; Gallagher WM
    Cancer Genomics Proteomics; 2007; 4(3):121-34. PubMed ID: 17878516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research and development for cancer biomarker].
    Nakagawa H
    Nihon Rinsho; 2012 May; 70(5):743-7. PubMed ID: 22619995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translating cancer genomes sequencing revolution into surgical oncology practice.
    Katsios C; Ziogas DE; Liakakos T; Zoras O; Roukos DH
    J Surg Res; 2012 Apr; 173(2):365-9. PubMed ID: 21195428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of DNA methylation for cancer detection: promises and challenges.
    Zhu J; Yao X
    Int J Biochem Cell Biol; 2009 Jan; 41(1):147-54. PubMed ID: 18834953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic approaches to the discovery of cancer biomarkers for early detection and personalized medicine.
    Honda K; Ono M; Shitashige M; Masuda M; Kamita M; Miura N; Yamada T
    Jpn J Clin Oncol; 2013 Feb; 43(2):103-9. PubMed ID: 23248327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of cancer using genomics.
    Vockley JG; Niederhuber JE
    BMJ; 2015 May; 350():h1832. PubMed ID: 26022222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges for biomarkers in cancer detection.
    Wagner PD; Verma M; Srivastava S
    Ann N Y Acad Sci; 2004 Jun; 1022():9-16. PubMed ID: 15251933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers.
    Camp RL; Neumeister V; Rimm DL
    J Clin Oncol; 2008 Dec; 26(34):5630-7. PubMed ID: 18936473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parallel anticancer drug development and molecular stratification to qualify predictive biomarkers: dealing with obstacles hindering progress.
    Garcia VM; Cassier PA; de Bono J
    Cancer Discov; 2011 Aug; 1(3):207-12. PubMed ID: 22586572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
    Lee JW; Figeys D; Vasilescu J
    Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer proteomics.
    Tan HT; Lee YH; Chung MC
    Mass Spectrom Rev; 2012; 31(5):583-605. PubMed ID: 22422534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in clinical oncoproteomics.
    Jain KK
    J BUON; 2007 Sep; 12 Suppl 1():S31-8. PubMed ID: 17935275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.